Drugs (Pharmaceuticals) – Page 44

F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

By Carl Zimmer and Christina Jewett

Centers for Disease Control and Prevention Containers and Packaging Drug Resistance (Microbial) Drugs (Pharmaceuticals) Eyes and Eyesight Factories and Manufacturing Food and Drug Administration Infections Recalls and Bans of Products

What to Know About the Recent Eye Drop Recalls

Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.

By Amanda Holpuch

Drugs (Pharmaceuticals) Kacsmaryk, Matthew Mifeprex (RU-486) Roe v Wade (Supreme Court Decision) Suits and Litigation (Civil) Texas

Texas Judge Hears Case to End Federal Approval of Abortion Pill

The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.

By Pam Belluck and Allison McCann

Drugs (Pharmaceuticals) Eli Lilly and Company Insulin Novo Nordisk A/S Prices (Fares, Fees and Rates)

Novo Nordisk Says It Will Slash the Price of Insulin

The company’s decision follows a similar move by its rival, Eli Lilly, this month.

By Rebecca Robbins

mosaec